✦ LIBER ✦

348 A phase II trial of docetaxel in patients (PTS) with anthracycline resistant (AR) metastatic breast cancer (MBC)

✍ Scribed by J.P. Guastalla; J. Bonneterre; P. Fumoleau; M. Piccart; M. Tubiana; B. Chevallier; C. Nieamann; M. Alakl; A. Nichol; A. Riva; M. Marty

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study in patients (PTS) with me

✍ Giocomi, N.; Pascual, M.; García, J.; Stagnaro, A.; Chirino, M.; Algamiz, C.; Es 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 173 KB

A phase II study of weekly docetaxel in

✍ Hugo E. R. Ford; Yoon-Sim Yap; David W. Miles; Andreas Makris; Marcia Hall; Liz 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 311 KB

Docetaxel plus cisplatin is effective fo

✍ Se Hoon Park; Eun Kyung Cho; Soo-Mee Bang; Dong Bok Shin; Jae Hoon Lee; Young Do 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 265 KB

O-49 A phase III trial of Gemcitabine pl

✍ S. Chan; R. Sharma; G. Romieu; T. Huober; T. Delozier; M. Tubiana-Hulin; A. Schn 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Phase II multicentre study of docetaxel

✍ Lortholary, A; Delozier, T; Monnier, A; Bourgeois, H; Bougnoux, P; Tubiana-Mathi 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

A multicenter phase II trial of docetaxe

✍ N. Karachaliou; Ch. Kouroussis; P. Papakotoulas; K. Kalbakis; K. Tryfonidis; N. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 194 KB